| Literature DB >> 32065592 |
Guiling Zhao1, Aaron Kaplan1,2, Maura Greiser1, W Jonathan Lederer1.
Abstract
The ATP-sensitive K+ channel (KATP) is formed by the association of four inwardly rectifying K+ channel (Kir6.x) pore subunits with four sulphonylurea receptor (SUR) regulatory subunits. Kir6.x or SUR mutations result in KATP channelopathies, which reflect the physiological roles of these channels, including but not limited to insulin secretion, cardiac protection, and blood flow regulation. In this issue of the JCI, McClenaghan et al. explored one of the channelopathies, namely Cantu syndrome (CS), which is a result of one kind of KATP channel mutation. Using a knockin mouse model, the authors demonstrated that gain-of-function KATP mutations in vascular smooth muscle resulted in cardiac remodeling. Moreover, they were able to reverse the cardiovascular phenotypes by administering the KATP channel blocker glibenclamide. These results exemplify how genetic mutations can have an impact on developmental trajectories, and provide a therapeutic approach to mitigate cardiac hypertrophy in cases of CS.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32065592 PMCID: PMC7269573 DOI: 10.1172/JCI135759
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808